Lorlatinib in ALK- and ROS1-positive NSCLC: the future has a start

di Facchinetti, Francesco, Friboulet, Luc
Pubblicato in Transl Lung Cancer Res (2018)

No room for statins in the quest for survival benefits in small cell lung cancer

di Facchinetti, Francesco, Tiseo, Marcello
Pubblicato in Transl Lung Cancer Res (2018)

Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date

di Facchinetti, Francesco, Friboulet, Luc
Pubblicato in Lung Cancer (Auckl) (2019)

Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary?

di Leonetti, Alessandro, Facchinetti, Francesco, Tiseo, Marcello
Pubblicato in Ann Transl Med (2018)

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

di Facchinetti, Francesco, Di Maio, Massimo, Tiseo, Marcello
Pubblicato in Cancers (Basel) (2020)

Cystic brain metastases and RET fusion in lung cancer

di Remon, Jordi, Facchinetti, Francesco, Besse, Benjamin, Tiseo, Marcello
Pubblicato in Transl Lung Cancer Res (2020)

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis

di Facchinetti, Francesco, Di Maio, Massimo, Perrone, Fabiana, Tiseo, Marcello
Pubblicato in Transl Lung Cancer Res (2021)

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

di Facchinetti, Francesco, Bordi, Paola, Leonetti, Alessandro, Buti, Sebastiano, Tiseo, Marcello
Pubblicato in Drug Des Devel Ther (2018)

New pathways in immune stimulation: targeting OX40

di Alves Costa Silva, Carolina, Facchinetti, Francesco, Routy, Bertrand, Derosa, Lisa
Pubblicato in ESMO Open (2020)

COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors

di Leonetti, Alessandro, Facchinetti, Francesco, Zielli, Teresa, Brianti, Elena, Tiseo, Marcello
Pubblicato in Eur J Cancer (2020)

Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with Gefitinib

di Gozzi, Fabrizio, Tiseo, Marcello, Facchinetti, Francesco, Gandolfi, Stefano, Rubino, Pierangela
Pubblicato in Case Rep Ophthalmol (2021)

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis

di Guaitoli, Giorgia, Tiseo, Marcello, Di Maio, Massimo, Friboulet, Luc, Facchinetti, Francesco
Pubblicato in Transl Lung Cancer Res (2021)

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

di Facchinetti, Francesco, Tiseo, Marcello, Di Maio, Massimo, Graziano, Paolo, Bria, Emilio, Rossi, Giulio, Novello, Silvia
Pubblicato in Transl Lung Cancer Res (2016)

Facts and new hopes on selective FGFR inhibitors in solid tumors

di Facchinetti, Francesco, Hollebecque, Antoine, Bahleda, Rastislav, Loriot, Yohann, Olaussen, Ken A, Massard, Christophe, Friboulet, Luc
Pubblicato in Clin Cancer Res (2019)

Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib

di Facchinetti, Francesco, Levy, Antonin, Ammari, Samy, Naltet, Charles, Lavaud, Pernelle, Aldea, Mihaela, Vasseur, Damien, Planchard, David, Besse, Benjamin
Pubblicato in Cancer Manag Res (2021)

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives

di Rossi, Giulio, Jocollé, Genny, Conti, Antonia, Tiseo, Marcello, Zito Marino, Federica, Donati, Giovanni, Franco, Renato, Bono, Francesca, Barbisan, Francesca, Facchinetti, Francesco
Pubblicato in Lung Cancer (Auckl) (2017)

Systemic thromboembolism from a misdiagnosed non-bacterial thrombotic endocarditis in a patient with lung cancer: A case report

di Perrone, Fabiana, Biagi, Andrea, Facchinetti, Francesco, Bozzetti, Francesca, Ramelli, Andrea, Vezzani, Antonella, Manca, Tullio, Gnetti, Letizia, Majori, Maria, Alfieri, Veronica, Tiseo, Marcello
Pubblicato in Oncol Lett (2020)

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors

di Dall’Olio, Filippo G., Abbati, Francesca, Facchinetti, Francesco, Massucci, Maria, Melotti, Barbara, Squadrilli, Anna, Buti, Sebastiano, Formica, Francesca, Tiseo, Marcello, Ardizzoni, Andrea
Pubblicato in Ther Adv Med Oncol (2020)

Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID‐19 patient

di Ugolotti, Maria C., Pedrazzini, Massimo, Silini, Enrico M., Missale, Gabriele, Silva, Mario, Franzini, Christian, Palmieri, Gerardo, Costi, Renato, Montali, Filippo, Gnappi, Elisa, Terroni, Lorenza, Colizzi, Elena, Meschi, Michele, Facchinetti, Francesco
Pubblicato in J Med Virol (2021)

Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies

di Facchinetti, Francesco, Loriot, Yohann, Brayé, Floriane, Vasseur, Damien, Bahleda, Rastislav, Bigot, Ludovic, Barbé, Rémy, Nobre, Catline, Combarel, David, Michiels, Stefan, Italiano, Antoine, Smolenschi, Cristina, Tselikas, Lambros, Scoazec, Jean-Yves, Ponce-Aix, Santiago, Besse, Benjamin, André, Fabrice, Olaussen, Ken A., Hollebecque, Antoine, Friboulet, Luc
Pubblicato in Clin Cancer Res (2024)